TPG and Bain Join Qiagen Takeover Race, $50/Share Floor Reported
QGEN sits 35% above its 52-week low of $32.53.
Summary
TPG and Bain Capital have joined the list of private equity firms interested in acquiring Qiagen, alongside previously reported EQT, Advent, and KKR. The report adds a minimum acceptable price of around $50 per share, implying a ~14% premium to the current $43.87. This follows a strategic review announced in March with Moelis and Goldman Sachs, and formal due diligence by two parties reported last month. The expanding bidder pool and explicit price floor suggest a competitive process is underway, increasing the likelihood of a deal. Watch for further reports on formal bids or a definitive agreement.
At the time of this announcement, QGEN was trading at $43.87 on NYSE in the Life Sciences sector, with a market capitalization of approximately $8.8B. The 52-week trading range was $32.53 to $57.82. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Seeking Alpha.